CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Baricitinib or AnakinraWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug2746 attendance by ambulance crew Wiki 1.00

Correlated MeSH Terms (3)


Name (Synonyms) Correlation
D000435 Alcoholic Intoxication NIH 1.00
D000428 Alcohol Drinking NIH 0.71
D004630 Emergencies NIH 0.19

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Clinical-epidemiological Characterization of COVID-19 Disease in Hospitalized Older Adults

Retrospective clinical-epidemiological study aimed at characterizing COVID-19 disease in adults older than 70 years, hospitalized in the "Perpetuo Socorro" Hospital of Albacete (Spain) from 09/03/2020 until 20/04/2020. Secondary objectives will be to analyze clinical-epidemiological characteristics of COVID-19 patients treated with Baricitinib or Anakinra, and to describe the efficacy and secondary effects of those drugs.

NCT04362943 COVID-19 Drug: Baricitinib or Anakinra

Primary Outcomes

Description: Mortality for all causes

Measure: Mortality

Time: 1 month

Secondary Outcomes

Description: Changes from admission to discharge thorax X-rays assessed by blinded radiologists

Measure: X-ray changes

Time: 1 month

Description: Changes from admission to discharge in Barthel index

Measure: Disability changes

Time: 1 month

Description: Changes from admission to discharge in Functional Ambulation Classification

Measure: Ambulation changes

Time: 1 month

Description: Changes from admission to discharge in lymphocyte count

Measure: lymphocyte count changes

Time: 1 month

Description: Changes from admission to discharge in C-Reactive Protein

Measure: C-Reactive Protein changes

Time: 1 month

Description: Changes from admission to discharge in Ferritin

Measure: Ferritin changes

Time: 1 month

Description: Changes from admission to discharge in D-Dimer

Measure: D-Dimer changes

Time: 1 month


No related HPO nodes (Using clinical trials)